124 related articles for article (PubMed ID: 22466813)
1. Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis.
Rios DR; Fernandes AP; Figueiredo RC; Guimarães DA; Ferreira CN; Simões E Silva AC; Carvalho MG; Gomes KB; Dusse LM
J Thromb Thrombolysis; 2012 May; 33(4):416-21. PubMed ID: 22466813
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of patients with congenital thrombotic thrombocytopenia purpura receiving a plasma-derived factor VIII (Koate) that contains ADAMTS13.
Chrisentery-Singleton T; Boggio LN; Carcao MD; Ibrahimi S; Khan O; Mahajerin A; Rajasekhar A; Sharma V; Steele M; Torres M; Rodino FJ; Carpenter SL
Haemophilia; 2023 Nov; 29(6):1638-1645. PubMed ID: 37855744
[TBL] [Abstract][Full Text] [Related]
3. ADAMTS13, von Willebrand Factor, Platelet Microparticles, Factor VIII, and Impact of Somatic Mutations in the Pathogenesis of Splanchnic Vein Thrombosis Associated with BCR-ABL-Negative Myeloproliferative Neoplasms.
Castelli R; Berzuini A; Manetti R; Delitala AP; Castro D; Sanna G; Sircana MC; Profili NI; Bartoli A; La Cava L; Lambertenghi Deliliers G; Donadoni M; Gidaro A
Life (Basel); 2024 Apr; 14(4):. PubMed ID: 38672756
[TBL] [Abstract][Full Text] [Related]
4. A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels.
de Vries PS; Reventun P; Brown MR; Heath AS; Huffman JE; Le NQ; Bebo A; Brody JA; Temprano-Sagrera G; Raffield LM; Ozel AB; Thibord F; Jain D; Lewis JP; Rodriguez BAT; Pankratz N; Taylor KD; Polasek O; Chen MH; Yanek LR; Carrasquilla GD; Marioni RE; Kleber ME; Trégouët DA; Yao J; Li-Gao R; Joshi PK; Trompet S; Martinez-Perez A; Ghanbari M; Howard TE; Reiner AP; Arvanitis M; Ryan KA; Bartz TM; Rudan I; Faraday N; Linneberg A; Ekunwe L; Davies G; Delgado GE; Suchon P; Guo X; Rosendaal FR; Klaric L; Noordam R; van Rooij F; Curran JE; Wheeler MM; Osburn WO; O'Connell JR; Boerwinkle E; Beswick A; Psaty BM; Kolcic I; Souto JC; Becker LC; Hansen T; Doyle MF; Harris SE; Moissl AP; Deleuze JF; Rich SS; van Hylckama Vlieg A; Campbell H; Stott DJ; Soria JM; de Maat MPM; Almasy L; Brody LC; Auer PL; Mitchell BD; Ben-Shlomo Y; Fornage M; Hayward C; Mathias RA; Kilpeläinen TO; Lange LA; Cox SR; März W; Morange PE; Rotter JI; Mook-Kanamori DO; Wilson JF; van der Harst P; Jukema JW; Ikram MA; Blangero J; Kooperberg C; Desch KC; Johnson AD; Sabater-Lleal M; Lowenstein CJ; Smith NL; Morrison AC
Blood; 2024 May; 143(18):1845-1855. PubMed ID: 38320121
[TBL] [Abstract][Full Text] [Related]
5. Factor VIII binding affects the mechanical unraveling of the A2 domain of von Willebrand factor.
Cao W; Cao W; Zhang W; Zheng XL; Zhang XF
J Thromb Haemost; 2020 Sep; 18(9):2169-2176. PubMed ID: 32544272
[TBL] [Abstract][Full Text] [Related]
6. The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver disease.
Scheiner B; Northup PG; Gruber AB; Semmler G; Leitner G; Quehenberger P; Thaler J; Ay C; Trauner M; Reiberger T; Lisman T; Mandorfer M
Liver Int; 2020 Jun; 40(6):1415-1426. PubMed ID: 32052552
[TBL] [Abstract][Full Text] [Related]
7. Gene-centric approach identifies new and known loci for FVIII activity and VWF antigen levels in European Americans and African Americans.
Tang W; Cushman M; Green D; Rich SS; Lange LA; Yang Q; Tracy RP; Tofler GH; Basu S; Wilson JG; Keating BJ; Weng LC; Taylor HA; Jacobs DR; Delaney JA; Palmer CD; Young T; Pankow JS; O'Donnell CJ; Smith NL; Reiner AP; Folsom AR
Am J Hematol; 2015 Jun; 90(6):534-40. PubMed ID: 25779970
[TBL] [Abstract][Full Text] [Related]
8. Von Willebrand factor levels in healthy blood donors and their association with blood group: A tertiary care hospital-based study.
Agrawal N; Pahuja S; Sharma S
Asian J Transfus Sci; 2023; 17(1):28-33. PubMed ID: 37188021
[TBL] [Abstract][Full Text] [Related]
9. VWF-ADAMTS13 axis dysfunction in children with sickle cell disease treated with hydroxycarbamide vs blood transfusion.
Fogarty H; Ahmad A; Atiq F; Doherty D; Ward S; Karampini E; Rehill A; Leon G; Byrne C; Geoghegan R; Conroy H; Byrne M; Budde U; Schneppenheim S; Sheehan C; Ngwenya N; Baker RI; Preston RJS; Tuohy E; McMahon C; O'Donnell JS
Blood Adv; 2023 Nov; 7(22):6974-6989. PubMed ID: 37773926
[TBL] [Abstract][Full Text] [Related]
10. VWF/ADAMTS13 Ratio as a Potential Predictive Biomarker for Acute Kidney Injury Onset in Cirrhosis.
Asada S; Namisaki T; Kaji K; Takaya H; Kubo T; Akahane T; Kawaratani H; Nishimura N; Takeda S; Masuda H; Shibamoto A; Inoue T; Iwai S; Tomooka F; Tsuji Y; Fujinaga Y; Kitagawa K; Mitoro A; Sato S; Matsumoto M; Yoshiji H
Dig Dis Sci; 2024 Mar; 69(3):851-869. PubMed ID: 38244124
[TBL] [Abstract][Full Text] [Related]
11. Normal cleavage of von Willebrand factor by ADAMTS-13 in the absence of factor VIII in patients with severe hemophilia A.
Chen J; Chung DW; Le J; Ling M; Konkle BA; López JA
J Thromb Haemost; 2013 Sep; 11(9):1769-72. PubMed ID: 23682841
[No Abstract] [Full Text] [Related]
12. Expresser phenotype determines ABO(H) blood group antigen loading on platelets and von Willebrand factor.
O'Donghaile D; Jenkins PV; McGrath RT; Preston L; Field SP; Ward SE; O'Sullivan JM; O'Donnell JS
Sci Rep; 2020 Oct; 10(1):18366. PubMed ID: 33110150
[TBL] [Abstract][Full Text] [Related]
13. Association of Haemostatic and Inflammatory Biomarkers with Nephropathy in Type 1 Diabetes Mellitus.
Domingueti CP; Fóscolo RB; Reis JS; Campos FM; Dusse LM; Carvalho Md; Braga Gomes K; Fernandes AP
J Diabetes Res; 2016; 2016():2315260. PubMed ID: 26770985
[TBL] [Abstract][Full Text] [Related]
14. ABO blood groups do not predict progression of traumatic intracranial hemorrhage.
Tutunjian AM; Arabian SS; Paolino J; Wolfe ES; Mahoney EJ; Hojman HM; Johnson BP; Bugaev N
J Clin Neurosci; 2021 Aug; 90():345-350. PubMed ID: 34275573
[TBL] [Abstract][Full Text] [Related]
15. Association between ABO haplotypes and the risk of venous thrombosis: impact on disease risk estimation.
Goumidi L; Thibord F; Wiggins KL; Li-Gao R; Brown MR; van Hylckama Vlieg A; Souto JC; Soria JM; Ibrahim-Kosta M; Saut N; Daian D; Olaso R; Amouyel P; Debette S; Boland A; Bailly P; Morrison AC; Mook-Kanamori DO; Deleuze JF; Johnson A; de Vries PS; Sabater-Lleal M; Chiaroni J; Smith NL; Rosendaal FR; Chasman DI; Trégouët DA; Morange PE
Blood; 2021 Apr; 137(17):2394-2402. PubMed ID: 33512453
[TBL] [Abstract][Full Text] [Related]
16. ABO Blood Group and Bleeding and Survival in VA-ECMO Patients.
Sun GH; Ortoleva JP; Lu SY; Vanneman MW; Tanaka K; Mazzeffi M; Dalia AA
J Intensive Care Med; 2023 Nov; 38(11):1015-1022. PubMed ID: 37291851
[TBL] [Abstract][Full Text] [Related]
17. Intradialytic Complement Activation Precedes the Development of Cardiovascular Events in Hemodialysis Patients.
Poppelaars F; Gaya da Costa M; Faria B; Berger SP; Assa S; Daha MR; Medina Pestana JO; van Son WJ; Franssen CFM; Seelen MA
Front Immunol; 2018; 9():2070. PubMed ID: 30271407
[No Abstract] [Full Text] [Related]
18. Human ABO Blood Groups and Their Associations with Different Diseases.
Abegaz SB
Biomed Res Int; 2021; 2021():6629060. PubMed ID: 33564677
[TBL] [Abstract][Full Text] [Related]
19. Effect of far-infrared radiation therapy on von Willebrand factor in patients with chronic kidney disease.
Yen CC; Hsu PC; Lin CC; Chen SC; Hsiao CY; Hwang SJ
Front Med (Lausanne); 2023; 10():1268212. PubMed ID: 37746066
[TBL] [Abstract][Full Text] [Related]
20. Comparison of thrombomodulin, vWF, and ADAMTS13 levels between preeclampsia and normal pregnancy.
Ahmad A; Mustafa G; Mazari N; Naveed MA
J Pak Med Assoc; 2024 Jan; 74(1):38-42. PubMed ID: 38219162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
